Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2022

Date: Tuesday, 1 March 2022 - Wednesday, 2 March 2022
Location: Rotterdam, The Netherlands

Home
|
Registration
|
Submissions
- Submission Guidelines
|
Agenda
|
Exhibition
|
Venue
|
Media
|

Conference Chair

Dominique PV de Kleijn
Professor Experimental Vascular Surgery; Professor Netherlands Heart Institute, University Medical Center Utrecht

Keynote Speakers

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas

Valérie Taly
CNRS Research Director, Professor and Group leader Translational Research and Microfluidics, Université Paris Cité

Sai Kiang Lim
Research Director, Institute of Medical Biology, A*STAR

Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands

Jan Lötvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles

Lorena Diéguez
Leader of the Medical Devices Research Group, INL- International Iberian Nanotechnology Laboratory

Overview

SelectBIO welcomes you to Circulating Biomarkers, Exosomes and Liquid Biopsy Europe 2022 to be held at the Hilton Rotterdam, The Netherlands.

This annual conference brings together academics and industry participants from around the world focused on research, biomarker analyses and therapeutics development leveraging the cargo from Exosomes and Extracellular Vesicles (EVs).

An important component of this conference is to focus upon the development of Liquid Biopsies utilizing circulating cell-free DNA (cfDNA), circulating tumour cells (CTCs) and other biomarkers found in biofluids.

Additionally, we focus at this conference on the Therapeutic and Drug Delivery Opportunities Enabled by Extracellular Vesicles (EVs). In this vein, key opinion leaders in this space will be presenting at this conference.

Presentations, Panel Discussions and Round-Table Workshops from key opinion leaders in the field form the basis of this conference and companies/vendors in the space participate to showcase their most up-to-date product and service offerings.

Rotterdam is an excellent host city for this conference with its excellent infrastructure, fast connections across Europe and easy access from around the world via Amsterdam-Schiphol.

**Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event. Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event.**Conference Held in Compliance with Dutch Government Guidelines**

Agenda Topics

Circulating Cell-Free DNA (cfDNA) for Liquid Biopsy Development

Companies Showcase
Technologies for Mutation Detection and Analysis

Circulating Tumour Cells (CTCs) for Liquid Biopsy Development

Companies Showcase
Emerging Technology Trends

Exosomes and Extracellular Vesicles (EV) Biomarker Potential

Proteins, DNA and Lipids
RNA Cargo

Exosomes and Extracellular Vesicles (EV) Research Trends
Exosomes and Extracellular Vesicles (EV) Studies in Various Diseases

Cancer
Cardiovascular Disease
CNS Disease

Isolation and Characterization of Exosomes and EV Classes
Modification and Engineering of Exosomes and EVs
Therapeutics Opportunities: Pharmaceutical/Drug Targeting of Disease using Exosomes/EVs

Biologics Delivered Using EVs
Drug Delivery Using EVs
Technologies for Engineering EVs for Therapeutics, Drug Delivery Vehicles

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Dimitri Aubert, Managing Director, NanoFCM Co., Ltd
Jan Brants, Regional Sales Director - France Benelux, NanoView Biosciences
Jean-Luc Fraikin, CEO, Spectradyne
Bernd Giebel, Group Leader, Institute for Transfusion Medicine, University Hospital Duisburg-Essen
Andrea Huxhold, Senior Scientific Marketing Manager, QIAGEN/PreAnalytiX
Stephanie Jordaens, Biomedical Scientist, University of Antwerp and Novosanis
Sven Rudolf Kreutel, Chief Executive Officer, Particle Metrix GmbH and CEO, Particle Metrix Inc., USA
Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC)
Jean Lewis, Associate Director, Research, Biological Dynamics
Stephane Mazlan, Regional Director (EMEA), Izon Science
Andreas Möller, Associate Professor, Group Leader and Head, Tumour Microenvironment Laboratory, QIMR Berghofer Medical Research Institute
D. Michiel Pegtel, Associate Professor, Amsterdam University Medical Center
Michael Pfaffl, Professor, Technical University of Munich
Matthew Rodrigues, Instrument Field Application Scientist, Luminex Corporation
Roel Schaapveld, Chief Executive Officer, InteRNA Technologies BV
Magdalena Schimke, Business Development and Sales, Single Cell Diagnostics, STRATEC Consumables GmbH
Edwin van der Pol, Assistant Professor, Amsterdam University Medical Center
Erik Vollebregt, Partner, Axon Lawyers
Ronald Vos, Business Development Manager, SensID
Bas WM van Balkom, Assistant Professor, University Medical Center Utrecht

Corporate Sponsors	Media Sponsors	Official Journal Partner	Networking

Add to Calendar ▼2022-03-01 00:00:002022-03-02 00:00:00Europe/LondonCirculating Biomarkers, Exosomes and Liquid Biopsy Europe 2022Circulating Biomarkers, Exosomes and Liquid Biopsy Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors